🏅 FDA Orphan Designation

Signifor

pasireotide

Manufacturer: Novartis Pharmaceuticals Corporation

Indicated for:

FDA-Approved Indications (1)

SIGNIFORï¿½ LAR is indicated for the treatment of patients with Cushingï¿½s disease for whom pituitary surgery is not an option or has not been curative.

Indications & Usage

1 INDICATIONS AND USAGE SIGNIFOR is a somatostatin analog indicated for the treatment of adult patients with Cushing's disease for whom pituitary surgery is not an option or has not been curative ( 1 ) 1.1 Cushing's Disease SIGNIFOR is indicated for the treatment of adult patients with Cushing's disease for whom pituitary surgery is not an option or has not been curative.

💙 Support Programs

View all →

Signifor LAR

Recordati

Copay card ↗Apply ↗

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.